Search research articles
Contact Us
Filters
Showing results (391-400 of 578) with videos related to
Page
of 58
Sort By:
American Journal of Obstetrics and Gynecology
|
January 24, 2016
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
Dirk Timmerman, Ben Van Calster, Antonia Testa, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 9, 2010
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies
Ignace Vergote, Eric Pujade-Lauraine, Sandro Pignata, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2017
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
Ilary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
Journal of the National Cancer Institute
|
December 29, 2020
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial
Céline Callens, Dominique Vaur, Isabelle Soubeyran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 11, 2021
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
Dirk Timmerman, François Planchamp, Tom Bourne, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 1, 2019
European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery
Denis Querleu, François Planchamp, Luis Chiva, et al.
Gynecologic Oncology
|
December 2, 2014
Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial
Anne Floquet, Ignace Vergote, Nicoletta Colombo, et al.
Gynecologic Oncology
|
June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer
Carlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Oncogene
|
July 4, 2023
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortium
Nicole Heinzl, Elisabeth Maritschnegg, Katarzyna Koziel, et al.
Gynecologic Oncology
|
September 22, 2016
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
Page
of 58
Search research articles
Search
Showing results (391-400 of 578) with videos related to
Sort By:
Page
of 58
American Journal of Obstetrics and Gynecology
|
January 24, 2016
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group
Dirk Timmerman, Ben Van Calster, Antonia Testa, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 9, 2010
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies
Ignace Vergote, Eric Pujade-Lauraine, Sandro Pignata, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 20, 2017
Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium
Ilary Ruscito, Dan Cacsire Castillo-Tong, Ignace Vergote, et al.
Journal of the National Cancer Institute
|
December 29, 2020
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial
Céline Callens, Dominique Vaur, Isabelle Soubeyran, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 11, 2021
ESGO/ISUOG/IOTA/ESGE Consensus Statement on pre-operative diagnosis of ovarian tumors
Dirk Timmerman, François Planchamp, Tom Bourne, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 1, 2019
European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery
Denis Querleu, François Planchamp, Luis Chiva, et al.
Gynecologic Oncology
|
December 2, 2014
Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 Trial
Anne Floquet, Ignace Vergote, Nicoletta Colombo, et al.
Gynecologic Oncology
|
June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancer
Carlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Oncogene
|
July 4, 2023
Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortium
Nicole Heinzl, Elisabeth Maritschnegg, Katarzyna Koziel, et al.
Gynecologic Oncology
|
September 22, 2016
Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, et al.
Page
of 58